Comparison between BIOCON IPO and DISHMAN PHARMACEUTICALS CHEMICALS IPO.
BIOCON IPO is a Mainboard Bookbuilding IPO proposed to list at NSE, BSE while DISHMAN PHARMACEUTICALS CHEMICALS IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of BIOCON IPO is up to ₹315.00 Cr whereas the issue size of the DISHMAN PHARMACEUTICALS CHEMICALS IPO is up to ₹60.09 Cr. The final issue price of BIOCON IPO is ₹315.00 per share and of DISHMAN PHARMACEUTICALS CHEMICALS IPO is ₹175.00 per share.
| BIOCON IPO | DISHMAN PHARMACEUTICALS CHEMICALS IPO | |
|---|---|---|
| Face Value | ₹5 per share | ₹10 per share |
| Issue Price (Lower) | ₹270.00 per share | ₹155.00 per share |
| Issue Price (Upper) | ₹315.00 per share | ₹175.00 per share |
| Issue Price (Final) | ₹315.00 per share | ₹175.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 1,00,00,000 shares | 34,33,500 shares |
| Fresh Issue Size (Amount) | up to ₹315.00 Cr | up to ₹60.09 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 1,00,00,000 shares | 34,33,500 shares |
| Issue Size Total (Amount) | up to ₹315.00 Cr | up to ₹60.09 Cr |
BIOCON IPO opens on Mar 11, 2004, while DISHMAN PHARMACEUTICALS CHEMICALS IPO opens on Mar 29, 2004. The closing date of BIOCON IPO and DISHMAN PHARMACEUTICALS CHEMICALS IPO is Mar 18, 2004, and Apr 07, 2004, respectively.
BIOCON IPO P/E ratio is 80.29, as compared to DISHMAN PHARMACEUTICALS CHEMICALS IPO P/E ratio of 12.64.
| BIOCON IPO | DISHMAN PHARMACEUTICALS CHEMICALS IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 68.38 | 99.994 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 61.53 | 74.99 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 80.29 | 12.64 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹3150.00 Cr. | ₹240.34 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹3.92 | ₹13.84 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 27.9 | 30.74 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the BIOCON IPO Retail Individual Investors (RII) are offered 25,00,000 shares while in DISHMAN PHARMACEUTICALS CHEMICALS IPO retail investors are offered 25,00,000 shares. Qualified Institutional Buyers (QIB) are offered 60,00,000 shares in BIOCON IPO and 17,16,700 shares in DISHMAN PHARMACEUTICALS CHEMICALS IPO.
| BIOCON IPO | DISHMAN PHARMACEUTICALS CHEMICALS IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 60,00,000 shares | 17,16,700 shares |
| NII | 15,00,000 shares | 8,58,400 shares |
| RII | 25,00,000 shares | 8,58,400 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 1,00,00,000 shares | 34,33,500 shares |
BIOCON IPO subscribed in total, whereas DISHMAN PHARMACEUTICALS CHEMICALS IPO subscribed .
